Summer vacation lasts roughly ten weeks. During that time, many kids experience a skill regression called the “summer slide.” ...

Half of the moon will be illuminated as it reaches its first quarter phase on Monday, June 2. The first quarter phase marks ...

Countless shadowed craters line the terminator all the way down to the moon's southern pole, while the 54-mile-wide (87 km) ...

See what moon phase it is tonight and find out when you can see the rest of the moon phases for 2025. Today, June 1, 2025, the moon is 5 days old and is in the Waxing Crescent phase of its lunar ...

Thanks to the Moon’s orbit around Earth, the angle of sunlight hitting the lunar surface and being reflected back to our ...

The university wrapped up Phase 1 renovations on the east side of the field just in time for the state track meet. Some of the upgrades include new restroom facilities, a concession stand ...

look to the southeast anytime after the Moon rises at about 9:45 p.m. Around 1 a.m., the Moon will reach its highest point: low in the Southern sky, less than 20 degrees elevation. Early commuters ...

A full moon is looming—and it will have a big impact on animals, especially those in the ocean. Recent studies show that many types of animals have biological clocks finely tuned to the cycles ...

Demographic, socioeconomic, and treatment patterns in malignant Brenner tumors: A National Cancer Database analysis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...

DEAR MISS MANNERS: Our daughter is finishing kindergarten and will start first grade in the fall. Neither the school nor our family are celebrating this milestone with a graduation or in any way ...

Clinical Trials at the Summit (CTS) 2025 brings together a diverse group of experts from around the world to discuss ongoing clinical trials and the latest data, all with the goal of achieving ...

Impact of tumor burden or focality in recurrent low-grade intermediate-risk non-muscle invasive bladder cancer on response to treatment with UGN-102: A substudy of the phase 3 ENVISION trial.